Prevention study for women at high risk for ovarian cancer
Study Contact Information:
Contact: Karen Lu, MD
by phone: 713-745-8902
or by email: [email protected]
This study is looking at whether removal of the fallopian tubes (salpingectomy) followed by removal of the ovaries (oophorectomy) at a later date closer to the time of natural menopause may reduce the risk of ovarian cancer nearly as much as removing both the ovaries and fallopian tubes at the same time (salpingo-oophorectomy) among women with an inherited BRCA1, BRCA2, BRIP1, RAD51C or RAD51D mutation. Removing the fallopian tubes only first and the ovaries at a later time closer to natural menopause may lessen menopausal symptoms while still lowering the risk for ovarian cancer.
Participants in this study will enroll in one of two groups. Participants will choose which group they enroll in based on their surgical preference.
M D Anderson Cancer Center
Contact: Karen Lu, MD by phone: 713-745-8902 or by email: [email protected]
University of Washington Cancer Center
Contact: Barb Norquist, MD by email: [email protected] or contact the study coordinator at: 206-616-3913
Women are eligible if they:
Women cannot participate if they:
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.